Clinical Trial Update: Docetaxel Versus Docetaxel Plus Cisplatin Versus Docetaxel Plus S-1 as Second-line Chemotherapy in Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing docetaxel alone versus docetaxel plus cisplatin versus docetaxel plus S-1 as second-line chemotherapy for metastatic gastric ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• DOCETAXEL (DOCETAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Cancer Center, Korea | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN